REDWOOD CITY, Calif., Oct. 24 /PRNewswire-FirstCall/ -- Genomic Health, Inc. today announced that the company will host a conference call and webcast on Tuesday, October 30, 2007 at 4:30 p.m. Eastern Time to discuss its third quarter 2007 financial results. The call and webcast will follow the release of the third quarter financial results after market close.
Conference Call Details
To access the live conference call via phone, please dial (877) 356-8064 from the United States and Canada or (706) 758-4314 internationally. The conference ID is 20930721. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through November 6 and may be accessed by dialing (800) 642-1687 from the United States and Canada or (706) 645-9291 internationally. The replay passcode is 20930721.
To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the company’s website at http://investor.genomichealth.com. Please connect to the web site at least 15 minutes prior to the call to allow for any software download that may be necessary.
About Genomic Health
Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test service, Oncotype DX(TM), which has been shown to predict the likelihood of breast cancer recurrence and the likelihood of chemotherapy benefit in a large portion of early-stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit http://www.genomichealth.com.
NOTE: Genomic Health, the Genomic Health logo, Oncotype, Oncotype DX and Recurrence Score are trademarks or registered trademarks of Genomic Health, Inc. All other trademarks and service marks are the property of their respective owners.
CONTACT: Brad Cole, +1-650-569-2281, investors@genomichealth.com; or
media, Emily Faucette, +1-650-569-2824, media@genomichealth.com, both of
Genomic Health, Inc.
Web site: http://www.genomichealth.com/
